Silja Mack

982 total citations
6 papers, 265 citations indexed

About

Silja Mack is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Silja Mack has authored 6 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Hematology, 2 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Silja Mack's work include Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Silja Mack is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Silja Mack collaborates with scholars based in Germany, Italy and Austria. Silja Mack's co-authors include Hartmut Döhner, Konstanze Döhner, Axel Benner, Richard F. Schlenk, Hans Salwender, Elisabeth Koller, Andreas Petzer, Detlef Haase, Frank Hartmann and Stephan Kremers and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Experimental Hematology and Oncology.

In The Last Decade

Silja Mack

6 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silja Mack Germany 4 158 89 67 63 52 6 265
C. Troff Germany 7 224 1.4× 91 1.0× 78 1.2× 57 0.9× 51 1.0× 13 301
Dennis Veldhuizen Netherlands 6 180 1.1× 57 0.6× 51 0.8× 87 1.4× 106 2.0× 7 316
Aline Clavert France 10 125 0.8× 86 1.0× 33 0.5× 55 0.9× 54 1.0× 23 225
Sujaatha Narayanan Canada 10 181 1.1× 81 0.9× 37 0.6× 61 1.0× 63 1.2× 43 272
Anne Banos France 10 167 1.1× 81 0.9× 33 0.5× 73 1.2× 57 1.1× 27 261
Emma Verner Australia 9 67 0.4× 132 1.5× 29 0.4× 81 1.3× 131 2.5× 37 221
Alexander Sternberg United Kingdom 7 203 1.3× 107 1.2× 19 0.3× 38 0.6× 46 0.9× 14 278
Cristina Ariola Italy 10 180 1.1× 81 0.9× 89 1.3× 70 1.1× 40 0.8× 15 315
S. Fenu Italy 9 301 1.9× 54 0.6× 86 1.3× 45 0.7× 30 0.6× 20 367
Raouf Ben Abdelali France 8 145 0.9× 41 0.5× 129 1.9× 55 0.9× 79 1.5× 15 262

Countries citing papers authored by Silja Mack

Since Specialization
Citations

This map shows the geographic impact of Silja Mack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silja Mack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silja Mack more than expected).

Fields of papers citing papers by Silja Mack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silja Mack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silja Mack. The network helps show where Silja Mack may publish in the future.

Co-authorship network of co-authors of Silja Mack

This figure shows the co-authorship network connecting the top 25 collaborators of Silja Mack. A scholar is included among the top collaborators of Silja Mack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silja Mack. Silja Mack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
2.
Schnaiter, Andrea, Peter Paschka, Marianna Rossi, et al.. (2013). NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG. Blood. 122(7). 1266–1270. 59 indexed citations
3.
Schnaiter, Andrea, Marianna Rossi, Peter Paschka, et al.. (2012). NOTCH1, SF3B1 and TP53 Mutations in Fludarabine-Refractory CLL Patients Treated with Alemtuzumab: Results From the CLL2H Trial of the Gcllsg. Blood. 120(21). 710–710. 6 indexed citations
4.
5.
Schlenk, Richard F., Konstanze Döhner, Silja Mack, et al.. (2010). Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukemia: German-Austrian Trial AMLHD98A. Journal of Clinical Oncology. 28(30). 4642–4648. 158 indexed citations
6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Troff Breakdown of academic impact, for papers by Dennis Veldhuizen Breakdown of academic impact, for papers by Aline Clavert Breakdown of academic impact, for papers by Sujaatha Narayanan Breakdown of academic impact, for papers by Anne Banos Breakdown of academic impact, for papers by Emma Verner Breakdown of academic impact, for papers by Alexander Sternberg Breakdown of academic impact, for papers by Cristina Ariola Breakdown of academic impact, for papers by S. Fenu Breakdown of academic impact, for papers by Raouf Ben Abdelali
Rankless by CCL
2026